<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Benign idiopathic intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> (BIH) in association with prothrombotic conditions has been reported with increasing frequency in the medical literature </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, activated protein C resistance (APCR) has been identified as a factor in some cases </plain></SENT>
<SENT sid="2" pm="."><plain>Because of its high prevalence, <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e> (FVL) is the most frequent <z:hpo ids='HP_0001928'>coagulation abnormality</z:hpo> associated with <z:hpo ids='HP_0005305'>cerebral venous thrombosis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Reduced craniospinal fluid reabsorption due to damaged arachnoid villi secondary to microthrombus formation has been proposed as an explanation for the physiopathology of BIH and FVL </plain></SENT>
<SENT sid="4" pm="."><plain>We describe two patients with a diagnosis of BIH, in whom the only risk factor was heterozygosity for FVL mutation </plain></SENT>
</text></document>